The evidence in this study suggests the potential of PKM2 in the T1D treatment in mouse models, but our study only validated the role of PKM2 in rodent experiments, more evidence is required to further validate these results in a cellular context. The gene discussed is PKM; the disease is type 1 diabetes mellitus.